
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title |
Status![]() |
---|---|---|---|---|---|---|---|
2020 | R43 | CA243757 | PAR-18-303 | ERVIN, ERIC | ELECTRONIC BIOSCIENCES, INC. | N6-Methyl-2-O-Methyladenosine Sequencing | Active |
2019 | R21 | CA236690 | RFA-CA-18-002 | KIM, HYUN JUNG | UNIVERSITY OF TEXAS, AUSTIN | A personalized colorectal cancer-on-a-chip for assessing tumor-microbiome crosstalk | Active |
2018 | R33 | CA223581 | RFA-CA-17-011 | CHENG, JI-XIN | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) | Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level | Active |
2022 | R33 | CA269015 | CA21-004 | ADEY, ANDREW | OREGON HEALTH & SCIENCE UNIVERSITY | Accessible high-throughput single-cell genome sequencing | Active |
2021 | R33 | CA255893 | RFA-CA-20-018 | SEELIG, GEORG | UNIVERSITY OF WASHINGTON | Joint receptor and protein expression immunophenotyping through split-pool barcoding | Active |
2020 | R44 | CA247353 | PAR-18-303 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC. | Spatial and single cell analysis of tumor microenvironment by seqFISH+ | Active |
2019 | R21 | CA240148 | RFA-CA-18-002 | ANGEL, PEGGY M | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Enzymatic Tools for 2D Tissue Localized and Deeper Proteomic Sequencing of Cancer Stromal Proteins | Active |
2022 | R33 | CA258012 | CA21-004 | KARGINOV, ANDREI V | UNIVERSITY OF ILLINOIS AT CHICAGO | Optogenetic Control of Tumor Initiation and Tumor Progression in vivo | Active |
2021 | R33 | CA256102 | RFA-CA-20-018 | GREENBERG, JOEL | DUKE UNIVERSITY | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens | Active |
2020 | R43 | CA250805 | PAR-18-303 | WANG, SHA | VIVID TECHNOLOGIES | New specific and rapid assay for in situ apoptosis labeling for cancer studies | Active |
2019 | R21 | CA240162 | RFA-CA-18-002 | KEUNG, ALBERT | NORTH CAROLINA STATE UNIVERSITY RALEIGH | Intracellular CRISPR gRNA assembly for massively multiplexed; one pot; (epi)genetic screening | Active |
2018 | R33 | CA225539 | RFA-CA-17-011 | JIANG, NING | UNIVERSITY OF TEXAS, AUSTIN | An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer | Active |
2022 | R21 | CA269091 | CA21-005 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions | Active |
2021 | R33 | CA257878 | RFA-CA-20-018 | HANSEN, ANDERS SEJR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer | Active |
2020 | R21 | CA240220 | RFA-CA-19-019 | ALEXANDRAKIS, GEORGIOS | UNIVERSITY OF TEXAS ARLINGTON | Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy | Active |
2019 | R21 | CA240199 | RFA-CA-18-002 | O'NEILL, RACHEL | UNIVERSITY OF CONNECTICUT STORRS | Development and Utilization of Splice-specific Antibodies | Active |
2022 | R33 | CA269094 | CA21-004 | MOELLERING, RAYMOND E | UNIVERSITY OF CHICAGO | Single-Cell Protein Activity Profiling in Breast Cancer Cells and Tissues | Active |
2021 | R33 | CA258016 | RFA-CA-20-018 | LIU, XUEFENG | OHIO STATE UNIVERSITY | Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics | Active |
2020 | R33 | CA247739 | RFA-CA-19-020 | MATRIX BHATNAGAR, PARIJAT | SRI INTERNATIONAL | T-cell Biofactories For Targeting Extracellular Matrix | Active |
2019 | R21 | CA240580 | RFA-CA-18-002 | MONTAGNA, CRISTINA | ALBERT EINSTEIN COLLEGE OF MEDICINE | Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions | Active |
2022 | R21 | CA261775 | CA21-003 | LIN, QIAO | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies | Active |
2021 | R44 | CA261523 | PAR-18-303 | HUNG, PAUL JU-SUNG | COMBINATI, INC. | Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring | Active |
2020 | R33 | CA240181 | RFA-CA-19-020 | COOKS, ROBERT GRAHAM | PURDUE UNIVERSITY | Advanced Development Of Desorption Electrospray Ionization Mass Spectrometry For Intraoperative Molecular Diagnosis Of Brain Cancer Using Pathology Biopsies | Active |
2019 | R33 | CA225458 | RFA-CA-18-003 | KETTENBACH, ARMINJA NADINE | DARTMOUTH COLLEGE | Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics | Active |
2022 | R21 | CA269099 | CA21-003 | YAKOVLEV, VLADISLAV V | TEXAS ENGINEERING EXPERIMENT STATION | Molecular and cellular imaging of bone biopsies using AI augmented deep UV Raman microscopy | Active |
2020 | R21 | CA251042 | RFA-CA-19-021 | GUPTA, GAUTAM | UNIVERSITY OF LOUISVILLE | Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens | Active |
2019 | R33 | CA225498 | RFA-CA-18-003 | CHEN, SIDI | YALE UNIVERSITY | Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers | Active |
2022 | R33 | CA269100 | CA21-004 | CHIU, BRIAN C-H | UNIVERSITY OF CHICAGO | A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research | Active |
2020 | R44 | CA243990 | PAR-18-303 | GURARD-LEVIN, ZACHARY | SAMDI TECH, INC. | Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities | Active |
2019 | R33 | CA225549 | RFA-CA-18-003 | TAVANA, HOSSEIN | UNIVERSITY OF AKRON | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | Active |
2018 | R33 | CA228979 | RFA-CA-17-011 | SCHRUM, ADAM G | UNIVERSITY OF MISSOURI-COLUMBIA | Multiplex matrix ELISA for T cell protein-interaction networks in cancer | Active |
2022 | R21 | CA269103 | CA21-003 | BLAINEY, PAUL CLARK | BROAD INSTITUTE, INC. | Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout | Active |
2020 | R21 | CA246457 | RFA-CA-19-019 | HATTORI, TAKAMITSU | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | Rational Generation Of High-performance Recombinant Antibodies To Post-translational Modifications | Active |
2019 | R33 | CA229042 | RFA-CA-18-003 | SCHNECK, JONATHAN P | JOHNS HOPKINS UNIVERSITY | A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells | Active |
2018 | R33 | CA229023 | RFA-CA-17-011 | TEWARI, MUNEESH (contact); WALTER, NILS G | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations | Active |
2022 | R21 | CA272014 | CA21-003 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON | Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations | Active |
2020 | R33 | CA236670 | RFA-CA-19-020 | HIGGINSON, DANIEL | SLOAN-KETTERING INST CAN RESEARCH | Comprehensive Breakpoint Analyses For Simultaneous Quantification Of All Dna Double Strand Break Repair Pathways | Active |
2019 | R33 | CA229068 | RFA-CA-18-003 | SCHIAVINATO EBERLIN, LIVIA | UNIVERSITY OF TEXAS, AUSTIN | Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation | Active |
2018 | R21 | CA229037 | RFA-CA-17-012 | GULLEY, MARGARET L | UNIV OF NORTH CAROLINA CHAPEL HILL | EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing | Active |
2022 | R21 | CA272014 | CA21-003 | NABA, ALEXANDRA | UNIVERSITY OF ILLINOIS AT CHICAGO | Enhanced mass-spectrometry-based approaches for in-depth profiling of the cancer extracellular matrix | Active |
2020 | R21 | CA240185 | RFA-CA-19-019 | LI, WEI | TEXAS TECH UNIVERSITY | Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip | Active |
2019 | R33 | CA235254 | RFA-CA-18-003 | FIOLKA, RETO PAUL | UT SOUTHWESTERN MEDICAL CENTER | Multiscale microscope for 3D cancer imaging in model organisms and organoids | Active |
2022 | R21 | CA267245 | CA21-005 | SHIBATA, DARRYL K | UNIVERSITY OF SOUTHERN CALIFORNIA | Photolithographic Tumor DNA Isolation | Active |
2022 | R33 | CA267219 | CA21-004 | LANDAU, DAN | WEILL MEDICAL COLL OF CORNELL UNIV | Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes | Active |
2020 | R21 | CA247638 | RFA-CA-19-019 | LIANG, FU-SEN | CASE WESTERN RESERVE UNIVERSITY | Spatiotemporal Epitranscriptome Editing Technology | Active |
2019 | R33 | CA235302 | RFA-CA-18-003 | DE VLAMINCK, IWIJN | CORNELL UNIVERSITY | Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer | Active |
2018 | R33 | CA217702 | RFA-CA-17-013 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity | Active |
2022 | R33 | CA272321 | CA21-004 | WANG, TZA-HUEI JEFF | JOHNS HOPKINS UNIVERSITY | A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies | Active |
2020 | R44 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues | Active |
2019 | R33 | CA235319 | RFA-CA-18-003 | YANG, JENNY J. | GEORGIA STATE UNIVERSITY | Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment | Active |